Cancer genetics

Genetic research

Breakthrough in Cancer Gene Therapy: CRISPR Lipid Nanoparticle-Spherical Nucleic Acids (LNP-SNAs)

Researchers at Northwestern University have developed a novel approach to delivering CRISPR gene therapy using lipid nanoparticle-spherical nucleic acids (LNP-SNAs). This method enhances gene transfection efficiency, reduces cytotoxicity, and improves cellular uptake compared to traditional lipid nanoparticles (LNPs). The study, published in the Proceedings of the National Academy of Sciences,

Cancer research

DNA Methylation Status of Regulatory Regions of Apoptosis-Associated Genes in Dystropy: Insights into Inverse Comorbidity of Huntington's Disease and Non-Small Cell Lung Cancer

Researchers at Tomsk National Research Medical Center in Russia have made a groundbreaking discovery regarding the DNA methylation status of regulatory regions of apoptosis-associated genes in dystropy, specifically in patients with Huntington's disease (HD) and non-small cell lung cancer (LC). The study investigated the inverse comorbidity of these

Genetic research

Targeting Macrophages in Glioblastoma Offers Promising Therapeutic Strategy

Glioblastoma, an aggressive brain tumor, is characterized by an immunosuppressive tumor microenvironment that contributes to treatment resistance and disease progression. Research has identified tumor-associated macrophages, comprising both resident microglia and bone marrow-derived macrophages, as a central component in supporting tumor growth, angiogenesis, and immune evasion. A systematic literature review and

Genetic research

Genomic Analysis Identifies TJP3 as a Prognostic Marker for Radiotherapy and Chemoradiotherapy in Oral Squamous Cell Carcinoma

Researchers from Seoul National University have conducted a study to analyze the genomic mutations and differentially expressed genes in primary oral squamous cell carcinoma (OSCC) tumors to identify prognostic markers for radiotherapy (RT) and concurrent chemo-radiation therapy (CCRT). The study used longitudinal whole-exome sequencing (WES) data from a patient who

Genetic research

Mitochondrial DNA Plays Pivotal Role in Chemoresistance in Esophageal Cancer

Researchers from Osaka University have made significant progress in understanding the mechanisms behind chemoresistance in esophageal cancer. According to the study, mitochondrial DNA (mtDNA) alterations, including mutations and copy number variations, drive chemoresistance in esophageal cancer. The investigators have identified the role of mtDNA in metabolic reprogramming, epithelial-mesenchymal transition (EMT)